Scientists have gained new insights into the part of the brain that gives us a sense of direction, by tracking neural activity with the latest advances in brain imaging techniques. The findings shed light on how the brain ...
Mar 22, 2023
0
98
Sarcopenia is a degenerative disease characterized by a pathological decrease in muscle strength that particularly affects older people. Researchers at the University of Barcelona have developed a new tool to assess the presence ...
Mar 13, 2023
0
0
A minimally invasive treatment that injects allograft disk tissue into the spine to relieve pain associated with degenerative disk disease provides significant improvement in pain and function over a sustained period, according ...
Mar 1, 2023
0
24
People living in disadvantaged neighborhoods—areas with higher poverty levels and fewer educational and employment opportunities—had an increased risk of dying within a month of being hospitalized for stroke, epilepsy ...
Feb 15, 2023
0
9
Many football fans fondly remember Rick Arrington as the Philadelphia Eagles' quarterback from 1970 to 1973, but his daughter's memories are tainted by years spent watching her dad suffer from late-stage chronic traumatic ...
Feb 9, 2023
0
1
A smart intraocular lens that can be inserted into the eye to diagnose Alzheimer's has been developed for the first time in Korea.
Jan 12, 2023
1
23
Seizures tend to get progressively worse over time in people with epilepsy, and a new study in mice suggests why that might be the case.
Dec 5, 2022
0
6
For decades, scientists have been interested in the effects of neurodegenerative disorders on the way people approach and produce visual art. They have sought the "artistic signatures" of diseases of the nervous system in ...
Nov 29, 2022
0
10
Regular use of drugs to lower cholesterol and control type 2 diabetes may lessen the risk of the degenerative eye disease associated with aging, known as AMD, finds a pooled data analysis of the available evidence, published ...
Nov 7, 2022
0
62
Partner companies Eisai and Biogen recently announced promising clinical trial results for their new Alzheimer's drug lecanemab. Over 18 months, patients treated with lecanemab experienced slower symptom progression than ...
Oct 14, 2022
0
5
